Finance

Lists
GENPF:OTCMKTS
Genix Pharmaceuticals Corp
0,014 USD
0,00%
(0,00) 1D
6-июл., 09:30:05 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GENPF...
Mkt. cap
1,22 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
0,04 USD
52-wk low
0,01 USD
Beta
-1,00
Shares outstanding
61,22 млн
Mkt. cap
1,22 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
0,04 USD
52-wk low
0,01 USD
Beta
-1,00
Shares outstanding
61,22 млн
News stories
From web sources and news partners
About Genix Pharmaceuticals Corp
CEO-
Employees-
Founded1993
HeadquartersВанкувер, Бритиш Колумбия, Канада
SectorPersonal care products
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025-ж. июл.
2025-ж. окт.
2026-ж. янв.
2026-ж. апр.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32,45 миң
30,90 миң
21,28 миң
23,20 миң
Operating expense
32,73 миң
31,18 миң
21,28 миң
23,20 миң
Total operating expenses
32,73 миң
31,18 миң
21,28 миң
23,20 миң
Operating income
-32,73 миң
-31,18 миң
-21,28 миң
-23,20 миң
Other non operating income
-7,96 миң
-2,35 миң
-2,42 миң
-3,70 миң
EBT including unusual items
-83,50 миң
-92,32 миң
-51,64 миң
-78,42 миң
EBT excluding unusual items
-83,50 миң
-86,68 миң
-51,64 миң
-78,42 миң
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-83,50 миң
-92,32 миң
-51,64 миң
-78,42 миң
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
25,00
129,00
164,00
66,00
Interest expense
-42,01 миң
-48,53 миң
-40,56 миң
-49,89 миң
Net interest expenses
-41,99 миң
-48,40 миң
-40,40 миң
-49,82 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-32,45 миң
-30,90 миң
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору